Microbial DNA sequencing reveals nutrient pollution and climate change reinforce lake eutrophication

Faculty of Arts and Science welcomes 12 new tenure-track faculty for 2024-2025

Concordia researchers identify a decline in microbial genetic richness in the western Arctic Ocean

New research paves the way for rapid and scalable genome engineering in yeast

Vitamin B5 may be the key to treating a dangerous rare genetic condition, according to new Concordia research

Concordia professor Dajana Vuckovic wins the 2023 Fred Beamish Award from the Canadian Society for Chemistry

Concordia hosts the Global BioFoundries Alliance Meeting 2022

Concordia biology prof awarded $6 million investment for innovative genomics-solution research

Two international postdocs are finding ways to defeat the virus that has left them stranded in Montreal

Concordia’s District 3 hosts its first online startup pitch night

How Concordia’s District 3 is playing a pivotal role in the emerging bioeconomy revolution

Concordia’s District 3 continues to set the standard for scientific entrepreneurship

Discover how Synthetic Biology is reshaping our world at 4TH SPACE

Measuring metabolites at the molecular level can have profound implications on patient care, says a Concordia researcher

How genome sequencing will make you healthier

Genome Foundry positions Concordia at the forefront of synthetic biology, says CASB co-founder Vincent Martin

Concordia’s new Genome Foundry means a faster pathway to understanding human beings

Canada’s first Genome Foundry is using robots to build synthetic genomes

The synthetic is real

$6 million for genomics research at Concordia

STEM SIGHTS: The Concordian who investigates species conservation with the Cree community

Meet the man who built Yahoo! into a digital empire

The micro medical device company that’s making major waves

Hey Mister, that's my CRISPR!

A bold future for brain-computer interfaces

Designer babies? No more cancer? Welcome to the exhilarating, terrifying world of DNA editing

$4.5 million to advance Concordia’s research strengths

Vincent Martin talks to Le Devoir

Concordia research harnesses the power of opium poppies

A $6 million investment to make feed go further